Key Takeaways
Specialist DSO affiliation can give specialists administrative relief, liquidity, and growth support while preserving clinical autonomy. Outcomes vary widely by partner, deal structure, and process quality.
-
Specialist DSO affiliation lets licensed specialists retain clinical authority while a DSO manages non-clinical operations such as HR, billing, compliance, and marketing.
-
Affiliation rates differ by specialty and career stage, which can help specialists gauge buyer demand and timing for a potential sale.
-
Deal terms, including cash at close, equity, and earnouts, can be some of the main factors that shape long-term financial results.
-
Non-clinical decisions such as scheduling, vendors, and software often shift to the DSO, so specialists should clarify boundaries in writing before signing.
What Specialist DSO Affiliation Means in Practice
A Dental Service Organization (DSO) is a business entity that provides non-clinical services to affiliated dental practices under a long-term contract. These services include human resources, billing, marketing, IT, supply chain, compliance, and financial reporting. The licensed dentist retains clinical authority, and the DSO handles the business infrastructure.
Specialist DSOs focus on one or more dental specialties such as orthodontics, endodontics, oral surgery, periodontics, and pediatric dentistry. They design support around specialty workflows, equipment needs, referral patterns, and staffing models. Specialty-focused DSOs have emerged to address the distinct challenges of specialty practice, including complex referral relationships and advanced clinical environments that general DSOs may not support as effectively.
General DSOs are usually built for high-volume general dentistry across many locations. They may include specialists within a larger portfolio, but their systems and processes often center on standardized general care rather than specialty-specific needs.
Affiliation with a specialist DSO typically includes the following:
-
Administrative relief: HR, payroll, billing, compliance, IT, and marketing handled by the DSO
-
Clinical autonomy: The specialist retains control over treatment decisions and patient care
-
Financial liquidity: Cash at close, potential equity ownership in the DSO platform, and growth support
-
Infrastructure investment: Access to modern equipment, technology, and facility upgrades
DSO Affiliation Statistics by Specialty: What the Data Shows
The ADA Health Policy Institute’s 2024 data provides a consistent benchmark on DSO affiliation rates across specialties. These figures come from HPI’s Dental Office Database, which covers approximately 198,117 of the 212,459 practicing dentists in the U.S., roughly 93% of the profession.
|
Specialty |
DSO Affiliation Rate (ADA HPI 2024) |
|---|---|
|
Orthodontists |
22.8% |
|
Oral & Maxillofacial Surgeons |
21.8% |
|
Endodontists |
20.8% |
|
Periodontists |
14.3% |
|
General Practitioners |
15.5% |
Orthodontists currently lead specialist DSO affiliation at nearly 23%. Oral and maxillofacial surgery is consolidating quickly and often attracts strong buyer interest. Endodontics and periodontics also show meaningful affiliation, with outcomes that can be attractive for well-positioned practices.
Affiliation varies by career stage as well. About 26.5% of dentists up to 10 years out of dental school are DSO-affiliated, compared to 9.1% for those more than 25 years out. This pattern reflects generational preferences and the growing role DSOs play in early-career practice models.
How Specialist DSO Affiliation Works: Step-by-Step Process
The affiliation process usually follows a structured sequence from initial valuation through closing. A sell-side advisor manages this process on the specialist’s behalf, protects the seller’s interests, and helps prevent downward renegotiation during due diligence.
-
Valuation and EBITDA Analysis: A CPA-led review of the practice’s financials determines true profitability and a defensible valuation. EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, is essentially operating profit before certain accounting adjustments. Advisors identify discretionary, personal, and non-recurring expenses to calculate adjusted EBITDA. Completing this diligence-grade work up front helps keep the agreed value intact later.
-
Go-to-Market Strategy: The advisor prepares a marketing profile and virtual data room, then presents the practice to a vetted pool of specialty-focused DSO buyers. The data room is an organized collection of financial, operational, and clinical information that buyers use to underwrite the practice.
-
Competitive Bidding: A structured, auction-style process invites multiple offers over a 45 to 60 day window. Many specialists see around 10 offers from vetted, pre-qualified buyers. Competition among buyers can be one of the main drivers of higher valuations and stronger terms.
-
Negotiation and LOI: The seller and advisor review offers, negotiate terms such as cash at close, equity, and earnouts, and sign a letter of intent (LOI). A sell-side advisor negotiates LOI details on the seller’s behalf, including earnout provisions and equity structure.
-
Due Diligence and Closing: The buyer’s team conducts a quality-of-earnings review, which is a detailed financial audit that tests whether EBITDA holds up under scrutiny. A strong sell-side advisor works to defend the agreed valuation through this stage. This stage typically runs 30 to 60 days, followed by final documentation and closing.
Financial Considerations for Specialists
Specialty practices can command higher EBITDA multiples than many general dentistry practices, reflecting stronger margins and durable referral networks. Industry sources report that specialty dental practices, including endodontics, oral surgery, periodontics, and orthodontics, have traded at EBITDA multiples in the range of 6.5x to 9.0x in 2026. Oral surgery often draws some of the strongest demand. Multiples still depend on practice size, EBITDA margin, provider mix, payer mix, growth, and location, so these ranges serve as directional guidance rather than guarantees.
For more detail on DSO deal structures, see McLerran & Associates’ guide to Key DSO Deal Terms Dentists Should Know and Negotiate.
DSO deals usually combine cash at close, rollover equity, and earnout provisions. Recent data suggests that many deals allocate around 65% of total consideration as cash at close and 35% as deferred value in 2026. That structure means a meaningful share of proceeds can depend on future performance and equity events.
Rollover equity, which is the portion of proceeds reinvested into the DSO platform, can represent up to 40% of a deal. That means you should underwrite the DSO like an investment. Examine its profitability, growth at existing offices, management team strength, and private equity backing.
Much of a DSO deal may qualify for long-term capital gains tax treatment instead of ordinary income rates. That difference can significantly affect after-tax proceeds. Consult a qualified tax advisor for guidance specific to your situation.
A competitive process can increase valuation by approximately 30% on average compared to selling to a single buyer, based on McLerran & Associates’ experience across roughly 2,000 successful practice sales.
Clinical Autonomy and Day-to-Day Operational Changes
Many specialists worry about losing clinical control when they consider DSO affiliation. In most DSO structures, the specialist retains clinical autonomy. Treatment decisions, patient care protocols, and standard of care remain with the licensed provider. State corporate practice of dentistry laws require that licensed dentists retain clinical authority, and DSOs cannot legally practice dentistry.
The non-clinical operating environment usually changes more than the clinical side. DSO influence over scheduling pace, production targets, preferred vendor lists, and software platforms can shape the clinical environment even when no one dictates treatment. Administrative functions such as HR, payroll, IT, compliance, and marketing typically move to the DSO.
Some specialists experience the shift as a major quality-of-life improvement because they can focus on patient care. Others feel the loss of business control more acutely. Before signing, specialists can request a written boundary map that explains which functions are handled at the platform level and which remain local to the practice.
How to Evaluate a DSO Partner: Red Flags and Due Diligence
DSOs vary widely in quality, culture, and financial strength. Evaluating a potential DSO partner with the same rigor used for any major investment can help protect your outcome. For a deeper framework, see McLerran & Associates’ guide on How to Vet DSO Partners Before Selling Your Dental Practice.
Key due diligence questions to ask include:
-
Financial health: Is the DSO profitable, and is revenue growing at existing affiliated offices or only through new acquisitions?
-
Management team: Does leadership have direct experience in your specialty, and what is their track record?
-
Private equity backing: Has the private equity firm behind the DSO completed similar transactions successfully, and where are they in their hold period?
-
Reputation: Talk to existing affiliated doctors off the record, without the DSO present, about their post-close experience.
-
Post-close environment: How does the DSO treat staff, and what does integration look like in practice?
-
Earnout mechanics: If the DSO controls expenses, headcount, and pricing after acquisition, it also controls whether your earnout target is achievable. Earnout definitions deserve as much scrutiny as the headline price.
Red flags can include DSOs that emerged after COVID with weak capitalization, those that promise high multiples but have poor retention among affiliated doctors, and those that are vague about equity terms, management fee structures, or the EBITDA definition used in earnout calculations. Common DSO affiliation contract pitfalls include non-compete clauses, restrictive covenants, revenue control provisions, and weak exit rights that can significantly limit a seller’s future options.
A sell-side advisor can vet buyers before they reach the table and exclude poorly run DSOs so specialists do not have to evaluate them directly.
Talk with a McLerran & Associates advisor to see how the firm screens DSO buyers and helps specialists avoid problematic partners.
Alternatives to DSO Affiliation
DSO affiliation represents one of several transition paths available to specialist practice owners. Other options include a doctor-to-doctor sale, remaining independent, or using a partial sale or partnership structure that vests into a full sale over time.
For smaller practices, generally under about $1.5 million in annual revenue, a private sale to an individual buyer may fit better. The DSO buyer pool often thins at lower revenue levels. Larger practices, particularly those generating $1.5 million or more, usually attract more attention from specialty-focused DSO platforms and can benefit from competitive bidding.
McLerran & Associates works both transition paths in roughly equal measure, with about 50% private-buyer transactions and 50% DSO affiliations. That dual-path experience allows the firm to prepare a side-by-side valuation that shows a specialist’s potential outcome in both markets before any decision is made. Choosing a path with full information can be one of the main foundations of a strong result.
Why Work With a Sell-Side Advisor?
A specialist usually sells a practice once in a career, while many DSOs negotiate acquisitions every week. That experience gap influences valuation, structure, and contract terms. Going into a sale without representation, or with a generalist broker who knows only a few DSOs, can leave a seller at a significant disadvantage.
McLerran & Associates is the nation’s largest dental-specific sell-side M&A advisory firm, with approximately 2,000 successful practice sales, approximately $2 billion in closed transaction volume, and more than 10,000 practices evaluated. The firm represents sellers only, so its incentives align with the practice owner. Its transaction rate of approximately 85 to 90% compares to an industry norm closer to 35 to 40%.
The team includes former investment bankers, practice-finance lenders, DSO buyers, CPAs, and advisors, with more than 100 years of collective dental-industry experience. Regional offices include Cleveland (led by Justin Klingshim), Atlanta (led by Matt Sutton), Northern Virginia (led by Andrew Kobylski), Los Angeles (led by Steven Au), and Phoenix (led by Brian Carroll, covering the Mountain West).
Connect with McLerran & Associates to discuss your practice, timing, and potential transition paths. Call (512) 900-7989 or email info@dentaltransitions.com.
Frequently Asked Questions About Specialist DSO Affiliation
What Is the Difference Between a DSO and a Private Equity Group?
A DSO provides non-clinical administrative and operational support to affiliated dental practices, handling HR, payroll, billing, compliance, IT, and marketing, while licensed dentists retain clinical authority. Private equity groups are investment firms that usually own or back DSOs and provide capital for acquisitions and growth. Most large DSOs are owned or partially owned by private equity firms that operate on hold periods of about 3 to 7 years. When a private equity backed DSO reaches the end of its hold period, it often recapitalizes or sells the platform, which can create significant returns for specialists who hold rollover equity.
How Long Does a Specialist DSO Affiliation Take?
The process from first conversation to closing typically runs 6 to 9 months for DSO transactions. Some deals extend to 12 to 18 months because of internal approvals and multi-layer due diligence. The competitive bid phase usually runs 45 to 60 days, followed by 30 to 60 days of due diligence and documentation. Specialists who prepare clean financials and practice data in advance, including a defensible EBITDA analysis, often move through the process more efficiently and with less value erosion during diligence.
Will I Lose Clinical Autonomy in a DSO Affiliation?
In most DSO affiliations, the specialist retains clinical autonomy. Treatment decisions, patient care, and standard of care remain with the licensed provider. State corporate practice of dentistry laws require this separation, and DSOs cannot legally practice dentistry. DSOs do influence non-clinical decisions such as scheduling pace, vendor selection, and software platforms, which can shape the practice environment. Before signing, specialists can request a written boundary map that explains which functions are managed at the DSO level and which remain local, and they can speak with existing affiliated doctors off the record about day-to-day life after affiliation.
How Much of a DSO Deal Is Cash Versus Equity?
DSO deals typically structure most total consideration as cash at close, with the remaining portion in rollover equity and earnout provisions. The exact split varies by deal, buyer, and practice profile, and rollover equity can represent a meaningful share of total value. Equity may be held at the joint-venture level, which can provide ongoing distributions, or at the holding-company level, which can offer a higher potential upside at a future recapitalization but usually without interim distributions. Because equity can represent a significant portion of total consideration, specialists can benefit from reviewing the DSO’s financial health, management team, and private equity backing as carefully as they would for any investment.
How Do I Know if a Specialty DSO Is Reputable?
Conversation with existing affiliated doctors, off the record and without the DSO present, often provides the clearest picture. Beyond that, specialists can review the DSO’s profitability and revenue trends at existing offices, evaluate leadership experience in the relevant specialty, and assess whether the private equity sponsor has a successful track record with similar platforms. Red flags include vague answers about equity terms or management fees, pressure to sign quickly, and poor retention among affiliated doctors. A sell-side advisor with deep DSO market knowledge can pre-screen buyers and guide specialists toward stronger platforms.
Maximizing Your Outcome in a DSO or Private Sale
Specialist DSO affiliation can be one of the more lucrative transition paths available to dental specialists, especially in consolidating segments such as orthodontics, oral surgery, endodontics, and pediatric dentistry. At the same time, the process is complex, and the experience gap between individual sellers and institutional buyers can be significant. The quality of the process, the strength of the partner, and the structure of the deal can often be measured in millions of dollars over a career.
With the track record described above, McLerran & Associates is positioned to help specialists compare DSO and private-buyer paths, understand realistic valuation ranges, and structure deals that align with clinical and personal goals.
Discuss your goals and potential timing with a McLerran & Associates advisor. Call (512) 900-7989 or email info@dentaltransitions.com.
